Hydration maintenance

Hydration maintenance refers to the body’s ability to regulate water balance via coordinated interaction between the central nervous system—specifically osmoreceptors and the hypothalamus—and the kidneys. Key molecules include arginine vasopressin (AVP), which is released in response to increased plasma osmolality and acts on vasopressin receptors (mainly type 2, V2R) in renal collecting duct cells, promoting translocation of aquaporin-2 (AQP2) water channels to the cell membrane and therefore increasing water reabsorption. Thirst mechanisms are engaged when AVP and renal mechanisms are inadequate, involving brain regions such as the subfornical organ (SFO) and organum vasculosum of the lamina terminalis (OVLT). Regulatory proteins such as LRBA, which anchor protein kinase A (PKA) in renal collecting ducts, are necessary for proper activation of AQP2 and water reabsorption. Dysregulation in any part of this system can lead to significant clinical problems in water balance, but “hydration maintenance” itself is not a discrete therapeutic target, receptor, enzyme, or transporter. Hydration maintenance is a physiological outcome, not a molecular entity, receptor, or therapeutic target. Specific targets for hydration-related therapies and interventions include vasopressin receptor type 2 (V2R), aquaporin-2 (AQP2), osmoreceptors, and associated signaling molecules such as LRBA, PKA, etc. To acquire structured data, identify and focus on the underlying molecular targets (e.g., “Vasopressin receptor type 2”, “Aquaporin-2”), not the process “hydration maintenance”.

Other names

Water homeostasisFluid balanceBody fluid regulationThirst regulation